Chile Healthcare and Pharmaceuticals Sector Report 2016/2017

  • ID: 4313073
  • Report
  • Region: Chile
  • 66 pages
  • EMIS, A Euromoney Institutional Investor Company
1 of 5
In 2015, Chile Was The Sixth Largest Pharmaceutical Market In Latin America In Terms Of Sales Volume, With 278Mn Units Sold.

FEATURED COMPANIES

  • Bupa Chile SA
  • Clínica Las Condes SA
  • Empresas Red Salud SA
  • Farmacias Ahumada SA
  • MORE
This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Chile. We present in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

Understand the key elements at play in the healthcare and pharmaceutical sector in Chile
Access forecasts for growth in the sector
View key data on healthcare spending and health insurance in Chile
Crystallise the forces both driving and restraining this sector in Chile
Build a complete perspective on sector trade, investment and employment
Understand the competitive landscape and who the major players are
View M&A activity and major deals
Gain an understanding of the regulatory environment for the sector in Chile
Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bupa Chile SA
  • Clínica Las Condes SA
  • Empresas Red Salud SA
  • Farmacias Ahumada SA
  • MORE
01 EXECUTIVE SUMMARY
Sector in Numbers 2015
Sector Overview
Sector Snapshot
Sector Outlook
Subsector Outlook
Driving Forces
Restraining Forces
02 SECTOR IN FOCUS
Main Economic Indicators
Main Sector Indicators
Global Positioning
Foreign Direct Investment
Employment and Wages
Number of Enterprises
03 COMPETITIVE LANDSCAPE
Highlights
Pharmaceutical Manufacturers Competition
Healthcare Services Competition
Health Insurance Competition
Top M&A Deals
M&A Activity, 2014-2016
04 COMPANIES IN FOCUS
Bupa Chile SA
Empresas Red Salud SA
Clínica Las Condes SA
Instituto de Diagnóstico SA –Clínica Indisa
Farmacias Ahumada SA
05 REGULATORY ENVIRONMENT
Government Policy
06 HEALTHCARE
Highlights
Main Events
Health Infrastructure
Focus Point – Number of SNSS Health Centres by Region
Focus Point –Number of Non-SNSS Health Centres by Region
Medical Professionals
Public Health Expenditure
Private Health Expenditure
Private Health Insurance
07 PHARMACEUTICALS
Highlights
Main Events
Production
Sales
External Trade
Imports
Exports
08 RETAIL CHANNELS
Number of Pharmacies
Retail Prices
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bupa Chile SA
  • Clínica Las Condes SA
  • Empresas Red Salud SA
  • Farmacias Ahumada SA
  • MORE
In 2015, Chile was the sixth largest pharmaceutical market in Latin America in terms of sales volume, with 278mn units sold, and the seventh biggest in terms of sales value, with USD 1.53bn, based on ex-factory prices (USD 2.32bn, based on retail prices). According to EMIS Insights estimates, Chile is particularly well-positioned in terms of per capita drug spending, ranking fifth in South America with sales of USD 84.6 per person in 2015. Over 2010-2015, total health expenditure rose at a CAGR of 8%, driven by a solid increase of government spending on healthcare. In 2015, Chile allocated 7.5% of its GDP for healthcare, a figure that will continue to grow in the short term. And yet, the country continues to rely on imports to meet its domestic demand for drugs. In 2010-2015 trade deficit in pharmaceuticals continually increased to reach USD 1bn in 2015.
Note: Product cover images may vary from those shown
5 of 5
Bupa Chile SA
Empresas Red Salud SA
Clínica Las Condes SA
Instituto de Diagnóstico SA –Clínica Indisa
Farmacias Ahumada SA
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll